Holen Sie sich die Stockscreener-App
7.5379
5.78%
-0.4621
Handel nachbörslich:
7.70
0.1621
+2.15%
Schlusskurs vom Vortag:
$8.00
Offen:
$7.5379
24-Stunden-Volumen:
3,100
Relative Volume:
0.45
Marktkapitalisierung:
$11.58M
Einnahmen:
$630.00K
Nettoeinkommen (Verlust:
$5.72M
KGV:
-22.07
EPS:
-0.3415
Netto-Cashflow:
$-6.75M
1W Leistung:
-7.48%
1M Leistung:
-14.63%
6M Leistung:
+6.77%
1J Leistung:
-2.99%
1-Tages-Spanne:
$7.5379
$7.5379
1-Wochen-Bereich:
$7.5379
$8.00
52-Wochen-Spanne:
$6.51
$13.27
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Firmenname
Addex Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ADXN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
7.5379 | 8.40M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten
Real time pattern detection on Grayscale Bitcoin Mini Trust stock3-Day Market Movement Forecast Analysis - Newser
Can GSK plc ADRhedged hit a new high this monthSmart Entry Signals for Active Traders - Newser
Combining price and volume data for Flux Power Holdings Inc.Free AI Driven Stock Trend Forecast - Newser
Most active stocks: US stocks with the highest trading volume today - Yahoo.co
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
LYRA Stock Quote Price and Forecast - CNN
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Addex Reports Q3 2021 Financial Results And Provides Corporate Update - Barchart.com
Addex Therapeutics (ADXN) Stock Price, News & Analysis - MarketBeat
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):